Home » Topics » Regulatory » Patents

Patents
RSS

SKB claims NK3 antagonists for pulmonary disorders

Aug. 30, 1996

SKB reports on PDE IV inhibitor research

Aug. 30, 1996

AChE inhibitor isolated from Penicillium at Kitasato Institute

Aug. 30, 1996

Theratech describes new rheumatiod arthritis diagnosis

Aug. 30, 1996

Beta3-adrenoceptor agonists described by Dainippon

Aug. 30, 1996

CCK antagonists from Warner-Lambert

Aug. 30, 1996

More squalene synthase inhibitors from Pfizer

Aug. 30, 1996

Estrogenic compounds from Sankyo

Aug. 30, 1996

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

DNA cleaving reagents from the University of Cincinnati

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 17, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 17, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
European Commission floats multiple fixes for MDR, IVDR
BioWorld MedTech
The European Union’s struggles with regulations for devices and in vitro diagnostics seem virtually endless, but the European Commission floated a series of...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.